122 related articles for article (PubMed ID: 38517481)
1. Handgrip Strength Predicts Survival in Patients With Pancreatic Cancer.
Freckelton J; Rajagopalan A; Moore GT; Croagh D
Pancreas; 2024 May; 53(5):e405-e409. PubMed ID: 38517481
[TBL] [Abstract][Full Text] [Related]
2. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.
Kays JK; Shahda S; Stanley M; Bell TM; O'Neill BH; Kohli MD; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):673-684. PubMed ID: 29978562
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions.
Nemer L; Krishna SG; Shah ZK; Conwell DL; Cruz-Monserrate Z; Dillhoff M; Guttridge DC; Hinton A; Manilchuk A; Pawlik TM; Schmidt CR; Talbert EE; Bekaii-Saab T; Hart PA
Pancreas; 2017 Oct; 46(9):1152-1157. PubMed ID: 28902785
[TBL] [Abstract][Full Text] [Related]
4. Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure.
Aslani A; Gill AJ; Roach PJ; Allen BJ; Smith RC
HPB (Oxford); 2010 Jun; 12(5):325-33. PubMed ID: 20590908
[TBL] [Abstract][Full Text] [Related]
5. ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma.
Li SS; Zhou CY; Liao R; Xiong L; Weng NN; Zhao YQ; Mason C; Gou HF; Yi C; Zhu Q
Medicine (Baltimore); 2020 Apr; 99(14):e19413. PubMed ID: 32243360
[TBL] [Abstract][Full Text] [Related]
6. Nutritional status and functional status of the pancreatic cancer patients and the impact of adjacent symptoms.
Santos I; Mendes L; Mansinho H; Santos CA
Clin Nutr; 2021 Nov; 40(11):5486-5493. PubMed ID: 34656030
[TBL] [Abstract][Full Text] [Related]
7. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
Yin JB; Li N; Cui MM; Wang X; Wang RT
BMC Gastroenterol; 2020 May; 20(1):143. PubMed ID: 32393273
[TBL] [Abstract][Full Text] [Related]
8. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
[TBL] [Abstract][Full Text] [Related]
9. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological significance of ISYNA1 expression in pancreatic ductal adenocarcinoma].
Zhou L; Sheng WW; Shi XY; Zhou JP; Dong M
Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):206-211. PubMed ID: 30861650
[No Abstract] [Full Text] [Related]
11. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.
Bachmann J; Ketterer K; Marsch C; Fechtner K; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
BMC Cancer; 2009 Jul; 9():255. PubMed ID: 19635171
[TBL] [Abstract][Full Text] [Related]
12. Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma.
Iwasaki T; Hiraoka N; Ino Y; Nakajima K; Kishi Y; Nara S; Esaki M; Shimada K; Katai H
Cancer Sci; 2019 Apr; 110(4):1491-1502. PubMed ID: 30776178
[TBL] [Abstract][Full Text] [Related]
13. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
14. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
[TBL] [Abstract][Full Text] [Related]
15. Hand grip strength-based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer.
Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Gan J; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):382-390. PubMed ID: 36447437
[TBL] [Abstract][Full Text] [Related]
16. A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients.
Saha G; Singh R; Mandal A; Das S; Chattopadhyay E; Panja P; Roy P; DeSarkar N; Gulati S; Ghatak S; Ghosh S; Banerjee S; Roy B; Ghosh S; Chaudhuri D; Arora N; Biswas NK; Sikdar N
Mol Med; 2020 Jun; 26(1):59. PubMed ID: 32552660
[TBL] [Abstract][Full Text] [Related]
17. Hand grip strength in patients with advanced cancer: A prospective study.
Hadzibegovic S; Porthun J; Lena A; Weinländer P; Lück LC; Potthoff SK; Rösnick L; Fröhlich AK; Ramer LV; Sonntag F; Wilkenshoff U; Ahn J; Keller U; Bullinger L; Mahabadi AA; Totzeck M; Rassaf T; von Haehling S; Coats AJS; Anker SD; Roeland EJ; Landmesser U; Anker MS
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1682-1694. PubMed ID: 37318103
[TBL] [Abstract][Full Text] [Related]
18. Cachexia in pancreatic cancer: new treatment options and measures of success.
Fearon KC; Baracos VE
HPB (Oxford); 2010 Jun; 12(5):323-4. PubMed ID: 20590907
[No Abstract] [Full Text] [Related]
19. Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma.
Zhuang J; Wang S; Wang Y; Wu Y; Hu R
BMC Cancer; 2024 May; 24(1):568. PubMed ID: 38714979
[TBL] [Abstract][Full Text] [Related]
20. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
